摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-Ethylsulfanylcarbothioylsulfanylpentanoic acid

中文名称
——
中文别名
——
英文名称
5-Ethylsulfanylcarbothioylsulfanylpentanoic acid
英文别名
5-ethylsulfanylcarbothioylsulfanylpentanoic acid
5-Ethylsulfanylcarbothioylsulfanylpentanoic acid化学式
CAS
——
化学式
C8H14O2S3
mdl
——
分子量
238.4
InChiKey
GHPAETCYWYEXRK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    13
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    120
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • NANOPARTICLES FOR CONTROLLED RELEASE OF ANTI-BIOFILM AGENTS
    申请人:University of Rochester
    公开号:EP2958557A1
    公开(公告)日:2015-12-30
  • Nanoparticles for Controlled Release of Anti-Biofilm Agents and Methods of Use
    申请人:Koo Hyun
    公开号:US20150374634A1
    公开(公告)日:2015-12-31
    The present invention relates to compositions and methods to treat and/or prevent biofilms and biofilm related diseases. The invention comprises a nanoparticle carrier (NPC) and at least one therapeutic agent therein. The NPC binds within biofilm and to surfaces at risk for biofilm formation and accumulation while providing local, sustained, enhanced and controlled delivery of the therapeutic agent, when triggered for release. In one embodiment, the NPC comprises pH-responsive elements that allows for specific delivery of the therapeutic agent when the local environment dictates that the agent should be delivered precisely when it is most needed.
  • US9566247B2
    申请人:——
    公开号:US9566247B2
    公开(公告)日:2017-02-14
  • [EN] NANOPARTICLES FOR CONTROLLED RELEASE OF ANTI-BIOFILM AGENTS<br/>[FR] NANOPARTICULES POUR LA LIBÉRATION CONTRÔLÉE D'AGENTS ANTI-FILM BIOLOGIQUE
    申请人:UNIV ROCHESTER
    公开号:WO2014130994A1
    公开(公告)日:2014-08-28
    The present invention relates to compositions and methods to treat and/or prevent biofilms and biofilm related diseases. The invention comprises a nanoparticle carrier (NPC) and at least one therapeutic agent therein. The NPC binds within biofilm and to surfaces at risk for biofilm formation and accumulation while providing local, sustained, enhanced and controlled delivery of the therapeutic agent, when triggered for release. In one embodiment, the NPC comprises pH-responsive elements that allows for specific delivery of the therapeutic agent when the local environment dictates that the agent should be delivered precisely when it is most needed.
  • [EN] NANOPARTICLES FOR CONTROLLED RELEASE OF ANTI-BIOFILM AGENTS AND METHODS OF USE<br/>[FR] NANOPARTICULES POUR LA LIBÉRATION CONTRÔLÉE D'AGENTS ANTI-BIOFILM ET PROCÉDÉS D'UTILISATION
    申请人:UNIV ROCHESTER
    公开号:WO2018026764A1
    公开(公告)日:2018-02-08
    The present invention relates to compositions and methods to treat and/or prevent biofilms and biofilm related diseases. The invention comprises a nanoparticle carrier (NPC) and at least one therapeutic agent therein. The NPC binds within biofilm and to surfaces at risk for biofilm formation and accumulation while providing local, sustained, enhanced and controlled delivery of the therapeutic agent, when triggered for release. In one embodiment, the NPC comprises pH-responsive elements that allows for specific delivery of the therapeutic agent when the local environment dictates that the agent should be delivered precisely when it is most needed.
查看更多